Evotec SE (OTCMKTS:EVTCY – Get Free Report) shares crossed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $3.98 and traded as low as $3.56. Evotec shares last traded at $3.57, with a volume of 33,224 shares traded.
Evotec Trading Down 1.9%
The company’s 50-day moving average is $3.98 and its 200 day moving average is $3.93. The firm has a market cap of $1.18 billion, a PE ratio of 8.71 and a beta of 0.98. The company has a current ratio of 2.57, a quick ratio of 2.50 and a debt-to-equity ratio of 0.53.
Evotec Company Profile
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
See Also
- Five stocks we like better than Evotec
- Dividend Payout Ratio Calculator
- As Trump Blocks Clean Energy, What’s Next for Renewables?
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- How a Superstore Strategy Fueled MINISO’s 20% Stock Surge
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Analysts Love These 3 Companies Reporting Earnings This Week
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.